论文部分内容阅读
The high morbidity and mortality of cancer make it one of the leading causes of global death,thus it is an urgent need to develop effective drugs for cancer therapy.Vascular endothelial growth factor receptor-2 (VEGFR2) acts as a central modulator of angiogenesis,and is therefore an important pharmaceutical target for developing anti-angiogenic agents.